117 related articles for article (PubMed ID: 38885922)
1. The Effect of Eicosapentaenoic and Docosahexaenoic Acid Supplementation on Coronary Artery Calcium Progression in Subjects with Diabetes and Coronary Artery Disease: A Secondary Analysis of a Randomized Trial.
Asbeutah AA; Daher R; Malik A; Hariri E; Alfaddagh A; Elajami TK; Welty FK
Am J Cardiol; 2024 Jun; ():. PubMed ID: 38885922
[TBL] [Abstract][Full Text] [Related]
2. Eicosapentaenoic and docosahexaenoic acid supplementation and coronary artery calcium progression in patients with coronary artery disease: A secondary analysis of a randomized trial.
Hariri E; Asbeutah AA; Malik A; Amangurbanova M; Chedid G; Daher R; Al Hammoud M; Welty FK
Atherosclerosis; 2023 Dec; 387():117388. PubMed ID: 38056242
[TBL] [Abstract][Full Text] [Related]
3. An omega-3 fatty acid plasma index ≥4% prevents progression of coronary artery plaque in patients with coronary artery disease on statin treatment.
Alfaddagh A; Elajami TK; Saleh M; Mohebali D; Bistrian BR; Welty FK
Atherosclerosis; 2019 Jun; 285():153-162. PubMed ID: 31055222
[TBL] [Abstract][Full Text] [Related]
4. Higher exercise capacity, but not omega-3 fatty acid consumption, predicts lower coronary artery calcium scores in women and men with coronary artery disease.
Chedid G; Malik A; Daher R; Welty FK
Atherosclerosis; 2023 Nov; 384():117168. PubMed ID: 37541921
[TBL] [Abstract][Full Text] [Related]
5. Effect of eicosapentaenoic acid/docosahexaenoic acid on coronary high-intensity plaques detected with non-contrast T1-weighted imaging (the AQUAMARINE EPA/DHA study): study protocol for a randomized controlled trial.
Nakao K; Noguchi T; Asaumi Y; Morita Y; Kanaya T; Fujino M; Hosoda H; Yoneda S; Kawakami S; Nagai T; Nishihira K; Nakashima T; Kumasaka R; Arakawa T; Otsuka F; Nakanishi M; Kataoka Y; Tahara Y; Goto Y; Yamamoto H; Hamasaki T; Yasuda S
Trials; 2018 Jan; 19(1):12. PubMed ID: 29310688
[TBL] [Abstract][Full Text] [Related]
6. Effect of Eicosapentaenoic Acid/Docosahexaenoic Acid on Coronary High-Intensity Plaques Detected Using Noncontrast T1-weighted Imaging: The AQUAMARINE EPA/DHA Randomized Study.
Nakao K; Noguchi T; Miura H; Asaumi Y; Morita Y; Takeuchi S; Matama H; Sawada K; Doi T; Hosoda H; Nakashima T; Honda S; Fujino M; Yoneda S; Kawakami S; Nagai T; Nishihira K; Kanaya T; Otsuka F; Nakanishi M; Kataoka Y; Tahara Y; Goto Y; Kusano K; Yamamoto H; Omae K; Ogawa H; Yasuda S
J Atheroscler Thromb; 2024 Feb; 31(2):122-134. PubMed ID: 37704431
[TBL] [Abstract][Full Text] [Related]
7. Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease.
Elajami TK; Alfaddagh A; Lakshminarayan D; Soliman M; Chandnani M; Welty FK
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710178
[TBL] [Abstract][Full Text] [Related]
8. Effect of Eicosapentaenoic and Docosahexaenoic Acids Added to Statin Therapy on Coronary Artery Plaque in Patients With Coronary Artery Disease: A Randomized Clinical Trial.
Alfaddagh A; Elajami TK; Ashfaque H; Saleh M; Bistrian BR; Welty FK
J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29246960
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: Implications for primary prevention.
Alfaddagh A; Kapoor K; Dardari ZA; Bhatt DL; Budoff MJ; Nasir K; Miller M; Welty FK; Miedema MD; Shapiro MD; Tsai MY; Blumenthal RS; Blaha MJ
Atherosclerosis; 2022 Jul; 353():11-19. PubMed ID: 35759823
[TBL] [Abstract][Full Text] [Related]
10. Coronary Artery Calcium Versus Pooled Cohort Equations Score for Primary Prevention Guidance: Randomized Feasibility Trial.
Muhlestein JB; Knowlton KU; Le VT; Lappe DL; May HT; Min DB; Johnson KM; Cripps ST; Schwab LH; Braun SB; Bair TL; Anderson JL
JACC Cardiovasc Imaging; 2022 May; 15(5):843-855. PubMed ID: 34922872
[TBL] [Abstract][Full Text] [Related]
11. Regression of human coronary artery plaque is associated with a high ratio of (18-hydroxy-eicosapentaenoic acid + resolvin E1) to leukotriene B
Welty FK; Schulte F; Alfaddagh A; Elajami TK; Bistrian BR; Hardt M
FASEB J; 2021 Apr; 35(4):e21448. PubMed ID: 33749913
[TBL] [Abstract][Full Text] [Related]
12. The triglyceride-lowering effects of a modest dose of docosahexaenoic acid alone versus in combination with low dose eicosapentaenoic acid in patients with coronary artery disease and elevated triglycerides.
Schwellenbach LJ; Olson KL; McConnell KJ; Stolcpart RS; Nash JD; Merenich JA;
J Am Coll Nutr; 2006 Dec; 25(6):480-5. PubMed ID: 17229894
[TBL] [Abstract][Full Text] [Related]
13. The effect of eicosapentaenoic and docosahexaenoic acids on physical function, exercise, and joint replacement in patients with coronary artery disease: A secondary analysis of a randomized clinical trial.
Alfaddagh A; Elajami TK; Saleh M; Elajami M; Bistrian BR; Welty FK
J Clin Lipidol; 2018; 12(4):937-947.e2. PubMed ID: 29752179
[TBL] [Abstract][Full Text] [Related]
14. ω-3 Ethyl ester results in better cognitive function at 12 and 30 months than control in cognitively healthy subjects with coronary artery disease: a secondary analysis of a randomized clinical trial.
Malik A; Ramadan A; Vemuri B; Siddiq W; Amangurbanova M; Ali A; Welty FK
Am J Clin Nutr; 2021 May; 113(5):1168-1176. PubMed ID: 33675344
[TBL] [Abstract][Full Text] [Related]
15. Which has the stronger impact on coronary artery disease, eicosapentaenoic acid or docosahexaenoic acid?
Iwamatsu K; Abe S; Nishida H; Kageyama M; Nasuno T; Sakuma M; Toyoda S; Inoue T
Hypertens Res; 2016 Apr; 39(4):272-5. PubMed ID: 26739870
[TBL] [Abstract][Full Text] [Related]
16. Association of blood levels of marine omega-3 fatty acids with coronary calcification and calcium density in Japanese men.
Sekikawa A; Mahajan H; Kadowaki S; Hisamatsu T; Miyagawa N; Fujiyoshi A; Kadota A; Maegawa H; Murata K; Miura K; Edmundowicz D; Ueshima H;
Eur J Clin Nutr; 2019 May; 73(5):783-792. PubMed ID: 30050076
[TBL] [Abstract][Full Text] [Related]
17. Effect of Omega-3 Fatty Acids on Coronary Plaque Morphology - A Serial Computed Tomography Angiography Study.
Motoyama S; Nagahara Y; Sarai M; Kawai H; Miyajima K; Sato Y; Matsumoto R; Takahashi H; Naruse H; Ishii J; Ozaki Y; Izawa H
Circ J; 2022 Apr; 86(5):831-842. PubMed ID: 34776470
[TBL] [Abstract][Full Text] [Related]
18. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G
Eur J Prev Cardiol; 2024 Jun; ():. PubMed ID: 38869144
[TBL] [Abstract][Full Text] [Related]
19. A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study.
Allaire J; Couture P; Leclerc M; Charest A; Marin J; Lépine MC; Talbot D; Tchernof A; Lamarche B
Am J Clin Nutr; 2016 Aug; 104(2):280-7. PubMed ID: 27281302
[TBL] [Abstract][Full Text] [Related]
20. Relationship Between Coronary Artery Calcium and Atherosclerosis Progression Among Patients With Suspected Coronary Artery Disease.
Hollenberg EJ; Lin F; Blaha MJ; Budoff MJ; van den Hoogen IJ; Gianni U; Lu Y; Bax AM; van Rosendael AR; Tantawy SW; Andreini D; Cademartiri F; Chinnaiyan K; Choi JH; Conte E; de Araújo Gonçalves P; Hadamitzky M; Maffei E; Pontone G; Shin S; Kim YJ; Lee BK; Chun EJ; Sung JM; Gimelli A; Lee SE; Bax JJ; Berman DS; Sellers SL; Leipsic JA; Blankstein R; Narula J; Chang HJ; Shaw LJ
JACC Cardiovasc Imaging; 2022 Jun; 15(6):1063-1074. PubMed ID: 35680215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
